SS
AMAG

Steve Schonfeld’s AMAG Pharmaceuticals AMAG Stock Holding History

Steve Schonfeld’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-84,437
Closed -$2.94M – 793
2016
Q4 		$2.94M Buy
+84,437
New +$2.52M 0.38% 69

Other funds holding AMAG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steve Schonfeld's AMAG Position: Q1 2017 in Review

Steve Schonfeld sold out of AMAG Pharmaceuticals (AMAG) in Q1 2017, closing a stake of 84,437 shares — an estimated $2.94M sold.

Steve Schonfeld first reported a position in AMAG in Q4 2016 and held it in 1 quarter. The position peaked at $2.94M in Q4 2016. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2017.

  • Steve Schonfeld reported no remaining AMAG Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Steve Schonfeld sold 84,437 AMAG Pharmaceuticals shares in Q1 2017, an estimated $2.94M.
  • Steve Schonfeld first reported a position in AMAG Pharmaceuticals in Q4 2016 and held it in 1 quarter.
  • Steve Schonfeld's AMAG Pharmaceuticals position peaked at $2.94M in Q4 2016.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2017.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2017, filed 15 May 2017.